China

Dr. Jean-Marc F. Blanchard's picture

Killing Chinese Life Sciences, Part II-Birth, Adolescence, and Adulthood

Dr. Jean-Marc F. Blanchard
Posted: Jul 23, 2024

The most recent and prominent United States (US) attempt to limit cooperation with Chinese life science businesses has stalled, but is hardly dead.

Making Signals out of Tesla Turns and its Implications for Foreign Firms

Tesla’s top brass, employees, and shareholders must be charged up about the surfeit of good news in the People’s Republic of China (PRC) over roughly the past three months after the world’s most famous electric vehicle (EV) firm hit a slew of potholes there. In late April, PRC Premier Li Qiang hosted Tesla CEO Elon Musk.

Mr. & Mrs. S.H. Wong Center for the Study of Multinational Corporations Orchestrates Successful Workshop on Chinese Overseas Ports in Africa and the Middle East

In early July 2024, the Mr. & Mrs. S.H. Wong Center for the Study of Multinational Corporations (Wong MNC Center) orchestrated a 1-1/2 day workshop on Chinese overseas ports in Africa and the Middle East.

Executive Director Jean-Marc F. Blanchard interviewed for FinanceAsia story on Implications of US Government Restrictions on Investment in China

On May 7, 2024, FinanceAsia interviewed Dr. Jean-Marc F. Blanchard, Founding Executive Director of the Mr. & Mrs. S.H. Wong Center for the Study of Multinational Corporations about the implications of US government restrictions on portfolio investment in Chinese assets, the direction of American policy on investment restrictions, and the potential direct and indirect effect of restrictions on China. Dr. Blanchard forecast more American Congressional measures to restrict portfolio investment in as well as foreign direct investment (FDI) into China.

No Turning Back the Clock for TikTok and its Broader Business Ramifications

The United States (U.S.) government (USG) has long wanted to enervate TikTok, which hosts short-form videos and whose owner is China’s ByteDance. USG and subnational efforts have come in the form of Presidential Executive Orders, Committee on Foreign Investment in the United States (CFIUS) divestiture orders, proposed legislation in the US Congress, limitations by states like Montana and Texas, and restrictive measures at universities.

Dr. Jean-Marc F. Blanchard's picture

Killing Chinese Life Sciences, Part I: Poisoning WuXi AppTec and its Kin

Dr. Jean-Marc F. Blanchard
Posted: Mar 26, 2024

In January 2024, Congressman Mike Gallagher, the Chair of the United States (US) House Committee on the Chinese Communist Party, introduced the “Biosecure Act,” which prohibits the US government (USG) from “procuring or obtaining biotechnology equipment or services produced or provided by a biotechnology company of concern,” participating in a c

Dr. Jean-Marc F. Blanchard's picture

The BRI is Dead? Long Live the BRI? Part IV-Bad Flail at the Rail(way) or How Not to Confront the BRI

Dr. Jean-Marc F. Blanchard
Posted: Jan 05, 2024

The Belt and Road Initiative (BRI) has generated so much commentary that it is conceivable that if one printed out all the relevant pages and laid them end-to-end the length might approach that of all the railway track laid under the aegis of the BRI![i] Further commentary seems even m

Second Takes on China’s Foreign Economic Policy after the 2023 Two Sessions and 20th Party Congress

China’s 20th Party Congress in October 2022 and its March 2023 “Two Sessions” revealed the new top leadership of the Chinese Communist Party (CCP), confirmed China’s top government officials, shed light on the CCP’s current agenda, concerns, and dogmas, promulgated new policies, and presented the government’s work program.

Mr. & Mrs. S.H. Wong Center for the Study of Multinational Corporations hosts fruitful workshop on Chinese Overseas Ports in Southeast and South Asia

In mid-December 2022 in the San Francisco Bay Area, the Mr. & Mrs. S.H. Wong Center for the Study of Multinational Corporations (Wong MNC Center) hosted a 1-1/2 day workshop entitled Chinese Overseas Ports in Southeast and South Asia: Profiling Problems and Progress.

Dissecting the Flawed Dissin of No Delisting…of Chinese Companies

The United States (US) Public Companies Accounting Oversight Board (PCAOB), part of the Securities and Exchange Commission, has a variety of duties, one of which is to “inspect registered public accounting firms’ audits and quality control systems.” It had been unable to do this, however, in the case of many US-listed Chinese companies because Beijing would not permit any accounting firms to share Chinese audits.

Pages